eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive About the journal Abstracting and indexing Subscription Contact Instructions for authors
3/2017
vol. 9
 
Share:
Share:
more
 
 
abstract:
Case report

Treatment of male breast cancer – case report

Łukasz Pietrzyński, Mateusz Rajchel, Tatiana Pietrzyńska

Online publish date: 2018/02/01
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Male breast cancer (MBC) is a rare medical condition, accounting for only 0.5% among all cases of breast cancer and 0.2% of all malignant neoplasms among men. Due to its rare occurrence, the studies concerning MBC comprise few affected patients and the number of individual case reports is limited. For this reason there are no gender-specific therapeutic standards for men and guidelines in MBC are not different from the pattern of action in this disease in women. Therefore, there is a need for detailed documentation of sporadically occurring cases of MBC to identify gender-specific aspects in the diagnosis and treatment of this condition. The authors present a case report of a 75-year-old patient with advanced breast cancer, along with an analysis of literature elaborating current methods for the detection, diagnostics, and treatment of male breast cancer.
keywords:

male breast cancer, bone metastases, palliative care

references:
Tkaczuk-Włach J, Sobstyl M, Jakiel G. Rak piersi – znaczenie profilaktyki pierwotnej i wtórnej. Prz Menopauzalny 2012; 4: 343-347.
Anthan R, Fried I, Rueckl T. Expression of cell cycle proteins in male breast carcinoma. World J Surg Oncol 2010; 8: 10-53.
Alteri R, Bertaut T, Brinton A. Cancer Facts and Figures 2015. American Cancer Society, Atlanta 2015; 58-72.
Patten DK, Sharifi LK, Fazel M. New approaches in the management of male breast cancer. Clin Breast Cancer 2013; 13: 309-314.
Sundriyal D, Kotwal S, Dawar R i wsp. Male breast cancer in India: series from a cancer research centre. Indian J Surg Oncol 2015; 12: 384-386.
Humphries MP, Jordan VC, Speirs V. Obesity and male breast cancer: provocative parallels? BMC Med 2015; 13: 134.
Smith TJ, Temin S, Alesi ER i wsp. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012; 30: 880-887.
Fisher B, Bryant J, Dignam JJ i wsp. Breast-conserving surgery with or without radiotherapy in older breast patients with early stage breast cancer: a systematic review and meta-analysis. Ann Surg Oncol 2014; 21: 786-794.
Baron MJ, McDonald PW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag 2006; 2: 277-282.
Husain ZA, Mahmood U, Hanlon A. Accelerated partial breast irradiation via brachytherapy: a patterns-of-care analysis with ASTRO consensus statement groupings. Brachytherapy 2011; 10: 479-485.
Miao H, Verkooijen HM, Chia KS i wsp. Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol 2011; 29: 4381-4386.
Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych 2014: rak piersi. Jassem J, Krzakowski M, Bobek-Billewicz B i wsp. Polskie Towarzystwo Onkologii Klinicznej. Aktualizacja na dzień 03.12.2014; 213-258.
Ober A, Bese N, Okkan S. Postoperative radiotherapy in male breast cancer. Radiother Oncol 2002; 64: 130.
Zabel A, Milker-Zabel S, Zuna i wsp. External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a single institute experience. Tumori 2005; 91: 151-155.
Stranzl H, Mayer R, Quehenberger F i wsp. Adjuvant radiotherapy in male breast cancer. Radiother Oncol 1999; 53: 29-35.
Cutuli B, Velten M, Dilhuydy JM i wsp. Male breast cancer: results of the treatments and prognostic factors in 690 cases. Int J Radiat Oncol Biol Phys 1998; 42: 2056.
Ribeiro G, Swindell R, Harris M i wsp. A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast 1996; 5: 141-146.
Ottini L, Palli D, Rizzo S i wsp. Male breast cancer. Crit Rev Oncol Hematol 2010; 73: 141-155.
Lopez M, Di Lauro L, Lazzaro B i wsp. Hormonal treatment of disseminated male breast cancer. Oncology 1985; 42: 345-349.
Ma C, Reinert T, Chmielewska I i wsp. Mechanisms of aromatase inhibitors resistance. Nat Rev Cancer 2015; 15: 261-275.
Horzela B. Leczenie raka piersi u mężczyzn. Prz Urol 2011; 6: 70.
Mauras N, O’Brien KO, Klein KO i wsp. Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metab 2000; 85: 2370-2377.
Leppert W, Nowakowska E. Rola radioterapii w leczeniu objawów zaawansowanej choroby nowotworowej. Med Paliat Prakt 2008; 2: 33-47.
Steel JL, Geller DA, Kim KH. Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting. Cancer 2016; 122: 1270-1282.
Leppert W, Milecki P, Łuczak J. Rola radioterapii w opiece paliatywnej. Nowa Medycyna 1/2000; http://www.czytelniamedyczna.pl/1313,rola-radioterapii-w-opiece-paliatywnej.html.
Lipton A, Richard L, Theriault D i wsp. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases. Cancer 2000; 88: 1082-1090.
Ciałkowska-Rysz A, Dzierżanowski T. Podstawowe zasady farmakoterapii bólu u chorych na nowotwory i inne przewlekłe, postępujące, zagrażające życiu choroby. Med Paliat 2014; 6: 1-6.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe